| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 1 | 11 | 2019 | 162 | 0.880 |
Why?
|
| Trans-Activators | 11 | 2019 | 701 | 0.750 |
Why?
|
| Nuclear Receptor Coactivator 3 | 15 | 2015 | 258 | 0.720 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2015 | 321 | 0.640 |
Why?
|
| Histone Acetyltransferases | 10 | 2008 | 226 | 0.610 |
Why?
|
| Twist-Related Protein 1 | 5 | 2023 | 36 | 0.440 |
Why?
|
| Mice | 48 | 2024 | 18207 | 0.400 |
Why?
|
| Mice, Knockout | 24 | 2021 | 3831 | 0.400 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2024 | 32 | 0.390 |
Why?
|
| Mice, Transgenic | 12 | 2024 | 2332 | 0.380 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2015 | 43 | 0.360 |
Why?
|
| Animals | 48 | 2024 | 33796 | 0.300 |
Why?
|
| Transcription Factors | 11 | 2014 | 2423 | 0.300 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2015 | 31 | 0.300 |
Why?
|
| Nuclear Proteins | 6 | 2023 | 1219 | 0.290 |
Why?
|
| Gene Editing | 2 | 2024 | 235 | 0.280 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 2594 | 0.280 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 316 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2019 | 1403 | 0.260 |
Why?
|
| Liver | 4 | 2021 | 1787 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 589 | 0.250 |
Why?
|
| Growth Hormone | 1 | 2006 | 129 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 183 | 0.220 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 156 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2015 | 235 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 318 | 0.200 |
Why?
|
| Hypothalamus | 3 | 2023 | 198 | 0.200 |
Why?
|
| Spermatogenesis | 3 | 2015 | 166 | 0.190 |
Why?
|
| Mammary Glands, Animal | 7 | 2013 | 448 | 0.190 |
Why?
|
| Oocytes | 2 | 2024 | 282 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2023 | 183 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 292 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 2337 | 0.170 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 15 | 0.170 |
Why?
|
| Phenylketonurias | 1 | 2021 | 20 | 0.170 |
Why?
|
| Memory | 1 | 2024 | 353 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 131 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 135 | 0.170 |
Why?
|
| Repressor Proteins | 4 | 2011 | 765 | 0.160 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 3711 | 0.160 |
Why?
|
| Neoplasms | 4 | 2023 | 2960 | 0.160 |
Why?
|
| Estradiol | 4 | 2015 | 462 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 230 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 159 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 708 | 0.150 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 8 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 151 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 964 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2020 | 201 | 0.140 |
Why?
|
| Glucose | 1 | 2023 | 853 | 0.140 |
Why?
|
| Organ Specificity | 3 | 2013 | 396 | 0.140 |
Why?
|
| Cell Movement | 4 | 2017 | 868 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 217 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 2010 | 0.140 |
Why?
|
| RNA, Messenger | 7 | 2012 | 2552 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2019 | 151 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 4 | 2017 | 625 | 0.140 |
Why?
|
| Female | 33 | 2024 | 70331 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 110 | 0.140 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.140 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 148 | 0.130 |
Why?
|
| Prealbumin | 2 | 2008 | 27 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 170 | 0.130 |
Why?
|
| Cell Plasticity | 1 | 2017 | 41 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2014 | 17 | 0.120 |
Why?
|
| Neurons | 3 | 2024 | 2012 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 617 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 877 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 430 | 0.120 |
Why?
|
| Uterus | 3 | 2012 | 542 | 0.120 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 1540 | 0.120 |
Why?
|
| Estrogens | 2 | 2012 | 427 | 0.120 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1366 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 54 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 55 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 4715 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 731 | 0.120 |
Why?
|
| Nuclear Receptor Coactivators | 3 | 2012 | 64 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2022 | 804 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 93 | 0.110 |
Why?
|
| Male | 23 | 2024 | 64409 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 227 | 0.110 |
Why?
|
| Gene Expression | 6 | 2013 | 1486 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 132 | 0.100 |
Why?
|
| Morphogenesis | 2 | 2013 | 185 | 0.100 |
Why?
|
| Body Weight | 4 | 2019 | 984 | 0.100 |
Why?
|
| Bufanolides | 1 | 2014 | 13 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 242 | 0.100 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2024 | 15 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 68 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 331 | 0.100 |
Why?
|
| Health | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hair Follicle | 1 | 2013 | 31 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 210 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2021 | 235 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 33 | 0.090 |
Why?
|
| Serotonin | 2 | 2024 | 209 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 184 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2013 | 4669 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 360 | 0.090 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 10 | 0.090 |
Why?
|
| Obesity | 2 | 2022 | 2381 | 0.090 |
Why?
|
| Protein Binding | 4 | 2021 | 1655 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2011 | 39 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 88 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 106 | 0.080 |
Why?
|
| Aging | 3 | 2015 | 1242 | 0.080 |
Why?
|
| Embryo Implantation | 1 | 2012 | 219 | 0.080 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 16 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 253 | 0.080 |
Why?
|
| Serine | 1 | 2011 | 161 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 517 | 0.080 |
Why?
|
| Lactation | 1 | 2011 | 197 | 0.080 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 207 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 670 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 24 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 585 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 718 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1206 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 290 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2017 | 2464 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1594 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 87 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 130342 | 0.070 |
Why?
|
| Exons | 2 | 2018 | 762 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 134 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 260 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 1921 | 0.070 |
Why?
|
| RNA Interference | 3 | 2015 | 493 | 0.070 |
Why?
|
| Apoptosis | 6 | 2013 | 1831 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 269 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2015 | 291 | 0.060 |
Why?
|
| Dwarfism | 1 | 2008 | 104 | 0.060 |
Why?
|
| Alleles | 3 | 2019 | 1677 | 0.060 |
Why?
|
| Receptors, Androgen | 3 | 2019 | 407 | 0.060 |
Why?
|
| Pregnancy | 5 | 2020 | 7418 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2009 | 296 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 416 | 0.060 |
Why?
|
| Histones | 1 | 2009 | 542 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 999 | 0.060 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 74 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 198 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 692 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2019 | 584 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 482 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 53 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 77 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2005 | 403 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 84 | 0.050 |
Why?
|
| Testis | 2 | 2004 | 389 | 0.050 |
Why?
|
| Genotype | 3 | 2008 | 2590 | 0.050 |
Why?
|
| Zygote | 1 | 2024 | 28 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 2004 | 73 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 97 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2006 | 306 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4664 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 93 | 0.050 |
Why?
|
| Anoctamins | 1 | 2023 | 13 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 69 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2015 | 234 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2023 | 25 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 167 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 691 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 327 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 19 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 74 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1572 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 203 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 132 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 88 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2002 | 32 | 0.050 |
Why?
|
| Cell Line | 3 | 2014 | 2557 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 61 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 136 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 279 | 0.040 |
Why?
|
| Disease Progression | 4 | 2015 | 2193 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 12 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 780 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 100 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 553 | 0.040 |
Why?
|
| Heterozygote | 2 | 2019 | 725 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 2003 | 165 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 715 | 0.040 |
Why?
|
| Superovulation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 177 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 19 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 53 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 73 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 49 | 0.040 |
Why?
|
| Ovary | 1 | 2003 | 351 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 666 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 830 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2019 | 767 | 0.040 |
Why?
|
| Motor Activity | 1 | 2003 | 492 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 748 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 429 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1008 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1209 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2011 | 901 | 0.040 |
Why?
|
| Keratin-14 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Chromatin | 1 | 2002 | 501 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 792 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 1109 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 117 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 256 | 0.030 |
Why?
|
| Placenta | 1 | 2002 | 501 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2019 | 292 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1384 | 0.030 |
Why?
|
| Leptin | 1 | 2019 | 215 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2011 | 436 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 615 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 479 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 576 | 0.030 |
Why?
|
| Mutation | 2 | 2024 | 6094 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 91 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 828 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 18 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 426 | 0.030 |
Why?
|
| Antibodies | 2 | 2009 | 320 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 262 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 112 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 224 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 104 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 19 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 231 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 713 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 128 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1100 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 313 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 922 | 0.030 |
Why?
|
| Pituitary Gland | 2 | 2005 | 73 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 66 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1074 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 37 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 256 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 75 | 0.020 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 355 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2013 | 45 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2005 | 171 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 424 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3368 | 0.020 |
Why?
|
| Ovariectomy | 2 | 2004 | 153 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 525 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 998 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1541 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 74 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 81 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 248 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 706 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 92 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 68 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 899 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 796 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 525 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 320 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 306 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 100 | 0.020 |
Why?
|
| Copulation | 1 | 2009 | 7 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2009 | 22 | 0.020 |
Why?
|
| Spermatids | 1 | 2009 | 25 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 224 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 661 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 355 | 0.020 |
Why?
|
| Oligospermia | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2895 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 131 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 302 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 198 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 38 | 0.020 |
Why?
|
| Cadherins | 1 | 2010 | 184 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4471 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Stem Cells | 2 | 2005 | 703 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1016 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 573 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 285 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 358 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1264 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 437 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 425 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 372 | 0.010 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 62 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 53 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 106 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 19 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 128 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 975 | 0.010 |
Why?
|
| Complement C3 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1456 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 400 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 25 | 0.010 |
Why?
|
| Haploidy | 1 | 2004 | 17 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 76 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 755 | 0.010 |
Why?
|
| Sperm Count | 1 | 2004 | 99 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 536 | 0.010 |
Why?
|
| Death | 1 | 2004 | 77 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 140 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2003 | 37 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 59 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 112 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 20 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 518 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2737 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 59 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 131 | 0.010 |
Why?
|
| Child | 1 | 2022 | 26097 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 213 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2004 | 254 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 600 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 341 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 275 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 422 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 225 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 679 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 253 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 488 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1947 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 466 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 852 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3471 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6197 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3168 | 0.010 |
Why?
|